Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Scher

Showing results (321-330 of 692) with videos related to

Pageof 70
Sort By:
Cancer|March 29, 2002
HER-2 profiling and targeting in prostate carcinomaMichael J Morris, Victor E Reuter, W Kevin Kelly, et al.
The Journal of Headache and Pain|October 6, 2017
Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial designDaniel Serrano, Richard B Lipton, Ann I Scher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2002
Nomogram for overall survival of patients with progressive metastatic prostate cancer after castrationOren Smaletz, Howard I Scher, Eric J Small, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1995
Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implicationsR A Ghossein, H I Scher, W L Gerald, et al.
Cancer|May 27, 2003
The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with with prostate cancerAndrew J Roth, Barry Rosenfeld, Alice B Kornblith, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Carboplatin-based chemotherapy with pharmacokinetic analysis for patients with hemodialysis-dependent renal insufficiencyR J Motzer, D Niedzwiecki, M Isaacs, et al.
The Journal of Urology|August 1, 1996
Methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy and cystectomy for unresectable bladder cancerS M Donat, H W Herr, D F Bajorin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Suramin and hydrocortisone: determining drug efficacy in androgen-independent prostate cancerW K Kelly, H I Scher, M Mazumdar, et al.
Cephalalgia : an International Journal of Headache|November 27, 2020
Headache complexity (number of symptom features) differentiates post-traumatic from non-traumatic headachesAnn I Scher, James S McGinley, R J Wirth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
American Society of Clinical Oncology endorsement of the Cancer Care Ontario Practice Guideline on nonhormonal therapy for men with metastatic hormone-refractory (castration-resistant) prostate cancerEthan M Basch, Mark R Somerfield, Tomasz M Beer, et al.
Pageof 70

Showing results (321-330 of 692) with videos related to

Sort By:
Pageof 70
Cancer|March 29, 2002
HER-2 profiling and targeting in prostate carcinomaMichael J Morris, Victor E Reuter, W Kevin Kelly, et al.
The Journal of Headache and Pain|October 6, 2017
Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial designDaniel Serrano, Richard B Lipton, Ann I Scher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2002
Nomogram for overall survival of patients with progressive metastatic prostate cancer after castrationOren Smaletz, Howard I Scher, Eric J Small, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1995
Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implicationsR A Ghossein, H I Scher, W L Gerald, et al.
Cancer|May 27, 2003
The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with with prostate cancerAndrew J Roth, Barry Rosenfeld, Alice B Kornblith, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Carboplatin-based chemotherapy with pharmacokinetic analysis for patients with hemodialysis-dependent renal insufficiencyR J Motzer, D Niedzwiecki, M Isaacs, et al.
The Journal of Urology|August 1, 1996
Methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy and cystectomy for unresectable bladder cancerS M Donat, H W Herr, D F Bajorin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Suramin and hydrocortisone: determining drug efficacy in androgen-independent prostate cancerW K Kelly, H I Scher, M Mazumdar, et al.
Cephalalgia : an International Journal of Headache|November 27, 2020
Headache complexity (number of symptom features) differentiates post-traumatic from non-traumatic headachesAnn I Scher, James S McGinley, R J Wirth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
American Society of Clinical Oncology endorsement of the Cancer Care Ontario Practice Guideline on nonhormonal therapy for men with metastatic hormone-refractory (castration-resistant) prostate cancerEthan M Basch, Mark R Somerfield, Tomasz M Beer, et al.
Pageof 70